Prescription of statins in suspected non‐alcoholic fatty liver disease and high cardiovascular risk, a population‐based study

BACKGROUND & AIMS: The prevalence of non‐alcoholic fatty liver disease (NAFLD) is increasing, with concomitant high incidence of lipoprotein abnormalities. Cardiovascular disease (CVD) is the main cause of death in subjects with NAFLD and management of dyslipidaemia is pivotal for prevention. We...

Descripción completa

Detalles Bibliográficos
Autores principales: van den Berg, Eline H., Wolters, Alba A. B., Dullaart, Robin P. F., Moshage, Han, Zurakowski, David, de Meijer, Vincent E., Blokzijl, Hans
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Metabolic Liver Disease
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6771756/
https://www.ncbi.nlm.nih.gov/pubmed/30968536
http://dx.doi.org/10.1111/liv.14116

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6771756/
https://www.ncbi.nlm.nih.gov/pubmed/30968536
http://dx.doi.org/10.1111/liv.14116

Ejemplares similares